CLRB - Cellectar Biosciences INC NEW

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.94 0.1 (2.02%)	---	---	-0.04 (-0.79%)	---	0.02 (0.4%)	-0.04 (-0.79%)	-0.04 (-0.79%)

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -3.39
Diluted EPS:: -3.39
Basic P/E:: -1.4867
Diluted P/E:: -1.4867
RSI(14) 1m:: 44.44
VWAP:: 5.02
RVol:: 0.7264

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	4.95 -0.07 (-1.39%)	Oct 15 16:32
1m	Price increase 1m	5.15 +0.07 (+1.38%)	Oct 15 16:30
1m	Price increase 1m	5.0 +0.05 (+1.11%)	Oct 15 15:53
1m	Price decrease 1m	4.87 -0.08 (-1.72%)	Oct 15 15:22
10m	Price decrease 10m	4.87 -0.17 (-3.28%)	Oct 15 15:18